Characteristic expression of p57/Kip2 in balloon cells in focal cortical dysplasia

Balloon cells are a pathognomonic cellular feature of various cortical malformations, including focal cortical dysplasia type IIb (FCD IIb), cortical tubers of tuberous sclerosis (TSC) and hemimegalencephaly (HME). In the present study, we investigated the immunohistochemical expression of p57/Kip2, a member of the Cip/Kip family of cyclin‐dependent kinase inhibitory proteins, in balloon cells in surgical specimens taken from 26, 17 and six patients with FCD IIb, TSC and HME, respectively. Characteristic dot‐like reactivity with a faint, intense, reticular and process‐like pattern was confined to the proximal portion of the cytoplasmic processes of the cells. Immunoelectron microscopy revealed the p57/Kip2 reactivity on intermediate filaments in the proximal portion of the processes. The immunohistochemical profile appeared similar to that of CD34; however, a double immunofluorescence study demonstrated that no cells showed reactivity for both p57/Kip2 and CD34. The frequencies of the p57/Kip2‐positive cells in FCD IIb and HME were significantly higher than those in TSC, suggesting that the balloon cells may be heterogeneous. These findings suggest some functional significance of the protein on the cytoplasmic processes of balloon cells and appear consistent with the notion that the cells are abnormally differentiated progenitor cells.

[1]  Eleonora Aronica,et al.  A neuropathology-based approach to epilepsy surgery in brain tumors and proposal for a new terminology use for long-term epilepsy-associated brain tumors , 2014, Acta Neuropathologica.

[2]  H. Nawa,et al.  mTOR signaling and its roles in normal and abnormal brain development , 2014, Front. Mol. Neurosci..

[3]  Y. Fujii,et al.  Suppressed Expression of Autophagosomal Protein LC3 in Cortical Tubers of Tuberous Sclerosis Complex , 2013, Brain pathology.

[4]  S. Gabriel,et al.  De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly , 2012, Nature Genetics.

[5]  E. Dicicco-Bloom,et al.  The multiple roles of the cyclin‐dependent kinase inhibitory protein p57KIP2 in cerebral cortical neurogenesis , 2012, Developmental Neurobiology.

[6]  Maria K. Lehtinen,et al.  Somatic Activation of AKT3 Causes Hemispheric Developmental Brain Malformations , 2012, Neuron.

[7]  C. Cepeda,et al.  Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex , 2012, Neurobiology of Disease.

[8]  E. Dicicco-Bloom,et al.  The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors. , 2011, Cerebral cortex.

[9]  E. Kavanagh,et al.  The hallmarks of CDKN1C (p57, KIP2) in cancer. , 2011, Biochimica et biophysica acta.

[10]  Maria Thom,et al.  The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission 1 , 2011, Epilepsia.

[11]  M. Thom,et al.  Balloon cells in human cortical dysplasia and tuberous sclerosis: isolation of a pathological progenitor-like cell , 2010, Acta Neuropathologica.

[12]  B. Joseph,et al.  The Cdk inhibitor p57Kip2 controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics , 2009, Oncogene.

[13]  A. Kakita,et al.  Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado–Joseph disease , 2009, Acta Neuropathologica.

[14]  Ji-Shin Lee,et al.  Pathophysiologic characteristics of balloon cells in cortical dysplasia , 2008, Child's Nervous System.

[15]  Arjune Sen,et al.  An Investigation of the Expression of G1-Phase Cell Cycle Proteins in Focal Cortical Dysplasia Type IIB , 2007, Journal of neuropathology and experimental neurology.

[16]  E. Aronica,et al.  Developmental lineage of cell types in cortical dysplasia with balloon cells. , 2007, Brain : a journal of neurology.

[17]  C. Elger,et al.  Differential Pi3K‐pathway Activation in Cortical Tubers and Focal Cortical Dysplasias with Balloon Cells , 2007, Brain pathology.

[18]  K. Nakayama,et al.  The Cyclin-dependent Kinase Inhibitors p57 and p27 Regulate Neuronal Migration in the Developing Mouse Neocortex* , 2007, Journal of Biological Chemistry.

[19]  Gary W. Mathern,et al.  Epileptogenesis in pediatric cortical dysplasia: The dysmature cerebral developmental hypothesis , 2006, Epilepsy & Behavior.

[20]  L. Martinian,et al.  Mcm2 labelling of balloon cells in focal cortical dysplasia , 2005, Neuropathology and applied neurobiology.

[21]  J. González-Martínez,et al.  Expression of Neural Stem Cell Surface Marker CD133 in Balloon Cells of Human Focal Cortical Dysplasia , 2005, Epilepsia.

[22]  T Tarui,et al.  Overexpression of p27 Kip 1, probability of cell cycle exit, and laminar destination of neocortical neurons. , 2005, Cerebral cortex.

[23]  C. Englund,et al.  Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B) , 2005, Acta Neuropathologica.

[24]  J. DeFelipe,et al.  Microanatomy of the dysplastic neocortex from epileptic patients. , 2004, Brain : a journal of neurology.

[25]  A. Schulze-Bonhage,et al.  CD34-immunoreactive balloon cells in cortical malformations , 2004, Acta Neuropathologica.

[26]  David J. Kwiatkowski,et al.  Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Rita Garbelli,et al.  Taylor's Cortical Dysplasia: A Confocal and Ultrastructural Immunohistochemical Study , 1999, Brain pathology.

[28]  J. Trojanowski,et al.  Internexin, MAP1B, and nestin in cortical dysplasia as markers of developmental maturity , 1997, Acta Neuropathologica.

[29]  J. Gutiérrez-Ramos,et al.  Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues , 1995, European journal of immunology.

[30]  M. Matise,et al.  A cell-autonomous requirement for Cip/Kip cyclin-kinase inhibitors in regulating neuronal cell cycle exit but not differentiation in the developing spinal cord. , 2007, Developmental biology.